Pretreatment Metabolic Parameters Measured by (18)F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C

OBJECTIVES: This study aimed to assess the pretreatment (18)F-fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) as a predictor of the pathological treatment response (PTR) of hepatocellular carcinoma (HCC) patients treated with PD-1 inhibitors and lenvatinib as a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guanyun, Zhang, Wenwen, Chen, Jiaxin, Luan, Xiaohui, Wang, Zhanbo, Wang, Yanmei, Xu, Xiaodan, Yao, Shulin, Guan, Zhiwei, Tian, Jiahe, Lu, Shichun, Xu, Baixuan, Ma, Guangyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204225/
https://www.ncbi.nlm.nih.gov/pubmed/35719917
http://dx.doi.org/10.3389/fonc.2022.884372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204225/
https://www.ncbi.nlm.nih.gov/pubmed/35719917
http://dx.doi.org/10.3389/fonc.2022.884372

Ejemplares similares